Loading patent…
AssigneesConsorcio Tecnologico De Sanidad Acuicola S.A., Universidad de Santiago de Chile
InventorsMario Cesar Gerardo TELLO REYES, Alvaro Eugenio SANTIBAÑEZ VARGAS, Mick Philippe PARRA MARDONEZ, Diego Enrique PAINE CABRERA, Claudia Andrea ZAPATA ROJAS, Andrea Del Pilar GARCES FERNANDEZ
Estimating the term…
The present invention falls within the technical field of aquaculture, and specifically, the invention relates to a specific solution for preventing and treating bacterial diseases using a Lactococcus lactis lactic acid bacterium transformed to produce an interferon type II (IFN II) immunostimulating cytokine, particularly interferon gamma (IFNg or IFNy). Said transformed bacterium has been deposited in the Chilean Microbial Genetic Resources Collection at INIA with accession number RGM 2416 dated Oct. 22, 2017.
A plasmid to transform L. lactis bacteria to produce interferon gamma (IFNγ) comprising:
A plasmid to transform L. lactis bacteria to produce interferon gamma (IFNg) comprising:
Dependencies are inferred from the claim text.